ORAL CAVITY CANCER
Clinical trials for ORAL CAVITY CANCER explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY CANCER trials appear
Sign up with your email to follow new studies for ORAL CAVITY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy plus chemo shows promise against tough head and neck cancers
Disease control CompletedThis early-phase trial tested adding the immunotherapy drug pembrolizumab to standard chemoradiation for people with advanced head and neck cancer. 59 participants received the combination to see if it was safe and how well it worked. The goal was to improve tumor control without…
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
New drug combo shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had returned or spread. The goal was to see if the combo could shrink tumors or slow the disease. Participants were grouped based on whether they had re…
Matched conditions: ORAL CAVITY CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC